Short Interest in Nephros, Inc. (NASDAQ:NEPH) Drops By 36.4%

Posted by Lars Charter on Dec 30th, 2024

Nephros, Inc. (NASDAQ:NEPH – Get Free Report) was the recipient of a large decrease in short interest in December. As of December 15th, there was short interest totalling 4,900 shares, a decrease of 36.4% from the November 30th total of 7,700 shares. Approximately 0.1% of the shares of the company are short sold. Based on an average trading volume of 11,400 shares, the short-interest ratio is currently 0.4 days.

Hedge Funds Weigh In On Nephros

A hedge fund recently bought a new stake in Nephros stock. Dimensional Fund Advisors LP bought a new stake in Nephros, Inc. (NASDAQ:NEPH – Free Report) in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 17,631 shares of the company’s stock, valued at approximately $37,000. Dimensional Fund Advisors LP owned about 0.17% of Nephros at the end of the most recent quarter. Institutional investors and hedge funds own 41.10% of the company’s stock.

Nephros Price Performance

Shares of NASDAQ:NEPH opened at $1.49 on Monday. The stock has a market capitalization of $15.71 million, a price-to-earnings ratio of -16.56 and a beta of 1.21. The business’s fifty day moving average price is $1.52 and its two-hundred day moving average price is $1.78. Nephros has a fifty-two week low of $1.36 and a fifty-two week high of $4.04.

Wall Street Analysts Forecast Growth

Separately, Benchmark reissued a “speculative buy” rating and set a $5.00 price objective on shares of Nephros in a report on Tuesday, November 12th.

Read Our Latest Analysis on Nephros

About Nephros

(Get Free Report)

Nephros, Inc, a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities.